Patents by Inventor Suad Efendic

Suad Efendic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of GLP-1 or analogs in treatment of myocardial infarction
    Publication number: 20030022823
    Abstract: This invention provides a method of reducing mortality and morbidity after myocardial infarction. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
    Type: Application
    Filed: April 12, 2001
    Publication date: January 30, 2003
    Inventor: Suad Efendic
  • Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
    Patent number: 6348447
    Abstract: The invention relates to the new use of gastrointestinal peptide hormones selected from the class consisting of glucagon-like peptide-1 (GLP-1) and derivatives thereof having anti-secretory effects and smooth muscle relaxatory properties in the gastrointestinal tract for the manufacture of a pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome. The invention also relates to a pharmaceutical composition comprising a combination of at least one member selected from said class consisting of GLP-1 and derivatives thereof with one or more other gastrointestinal peptide hormone(s) or derivative(s) thereof together with pharmacologically acceptable additives and to a method of treating functional dyspepsia or irritable bowel syndrome or both by administering an effective amount of at least one member of said class consisting of GLP-1 and derivatives thereof having effects and properties as mentioned above.
    Type: Grant
    Filed: February 3, 2000
    Date of Patent: February 19, 2002
    Inventors: Per Hellström, Suad Efendic
  • Use of GLP-1 or analogs in treatment of myocardial infarction
    Patent number: 6277819
    Abstract: This invention provides a method of reducing mortality and morbidity after myocardial infarction. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: August 21, 2001
    Assignee: Eli Lilly and Company
    Inventor: Suad Efendic
  • Use of a peptide
    Publication number: 20010002394
    Abstract: GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds can be used to provide a medicament for use in the treatment of diabetes in a regimen which additionally comprises treatment with an oral hypoglycaemic agent. A strong synergistic effect is observed.
    Type: Application
    Filed: January 4, 2001
    Publication date: May 31, 2001
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity
    Patent number: 6191102
    Abstract: This invention relates the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight.
    Type: Grant
    Filed: October 30, 1997
    Date of Patent: February 20, 2001
    Assignee: Eli Lilly and Company
    Inventors: Richard D. DiMarchi, Suad Efendic
  • Use of GLP-1 or analogs to abolish catabolic changes after surgery
    Patent number: 6006753
    Abstract: This invention provides a method of attenuating post-surgical catabolic changes and hormonal responses to stress. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: December 28, 1999
    Assignee: Eli Lilly and Company
    Inventor: Suad Efendic
  • Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
    Patent number: 5739147
    Abstract: Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseasesCyclohexane derivatives of the formula I ##STR1## wherein R.sup.2, R.sup.4 and R.sup.5 have the given meanings and a process for their preparation are described. The compounds have useful pharmacological properties and can therefore be used as pharmaceuticals.
    Type: Grant
    Filed: May 21, 1997
    Date of Patent: April 14, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Horst Hemmerle, Gerrit Schubert, Hans-Jorg Burger, Andreas Herling, Suad Efendic'
  • Use of a peptide
    Patent number: 5631224
    Abstract: The invention employs GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Grant
    Filed: October 13, 1994
    Date of Patent: May 20, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Peptide
    Patent number: RE37302
    Abstract: The invention employs GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Grant
    Filed: February 19, 1998
    Date of Patent: July 31, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk